logo
#

Latest news with #FormS-1

NMP Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
NMP Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Business Upturn

timea day ago

  • Business
  • Business Upturn

NMP Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Palo Alto, California, June 30, 2025 (GLOBE NEWSWIRE) — NMP Acquisition Corp. (the 'Company') today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Company's initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. Up to $300,000 of interest earned on the funds held in the trust account, in the aggregate, may be released to us to fund our working capital requirements. In addition, we may withdraw interest earned on the trust to pay our income and franchise taxes, if any. The units are expected to trade on the Nasdaq Global Market ('Nasdaq') under the ticker symbol 'NMPAU' beginning on July 1, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols 'NMP' and 'NMPAR,' respectively. Maxim Group LLC is acting as the sole book-running manager for the offering. The Company has granted the underwriter a 45-day option to purchase up to 1,500,000 additional units at the initial public offering price less the underwriting discount to cover over-allotments, if any. The offering is expected to close on July 2, 2025, subject to customary closing conditions. A registration statement on Form S-1 (File No. 333-286985) (the 'Registration Statement') relating to the securities to be sold in the initial public offering, as amended, was declared effective by the U.S. Securities and Exchange Commission (the 'SEC') on June 30, 2025. The offering is being made only by means of a prospectus. When available, copies of the prospectus relating to this offering may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, by telephone at (212) 895-3745 or by email at [email protected], or by accessing the SEC's website, This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About NMP Acquisition Corp. NMP Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Forward-Looking Statements This press release contains statements that constitute 'forward-looking statements,' including with respect to the Company's initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Registration Statement and related preliminary prospectus filed in connection with the initial public offering with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Contact Information NMP Acquisition FigueroaCEOAttn: Investor Relations E-mail: mailto:[email protected]

Accelerant Holdings Announces Public Filing of Registration Statement for Initial Public Offering
Accelerant Holdings Announces Public Filing of Registration Statement for Initial Public Offering

Business Wire

time2 days ago

  • Business
  • Business Wire

Accelerant Holdings Announces Public Filing of Registration Statement for Initial Public Offering

ATLANTA--(BUSINESS WIRE)--Accelerant Holdings ('Accelerant') announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ('SEC') relating to a proposed underwritten initial public offering of its Class A common shares. The timing of the offering, number of Class A common shares to be offered and the price range for the proposed offering have not yet been determined. The Class A common shares to be offered and sold in the proposed offering are expected to be offered by Accelerant and certain selling shareholders. The initial public offering is subject to market and other conditions. Accelerant intends to list its Class A common shares on the New York Stock Exchange under the ticker symbol 'ARX.' Morgan Stanley & Co. LLC is acting as lead left active bookrunner, Goldman Sachs & Co. LLC is acting as lead right active bookrunner, and BMO Capital Markets Corp. and RBC Capital Markets, LLC are acting as active bookrunners for the proposed offering. The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the proposed offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at prospectus@ Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, or by email at prospectus-ny@ BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036, by telephone at (800) 414-3627, or by email at bmoprospectus@ RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, 8th Floor, New York, NY 10281, by telephone at (877) 822-4089, or by email at equityprospectus@ A registration statement relating to the Class A common shares has been filed with the SEC but has not yet become effective. The Class A common shares may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. ABOUT ACCELERANT Accelerant is a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers. Accelerant was founded in 2018 by a group of longtime insurance industry executives and technology experts who shared a vision of rebuilding the way risk is exchanged – so that it works better, for everyone. The Accelerant risk exchange does business across 22 different countries and more than 500 specialty insurance products.

NIQ Announces Filing of Registration Statement for Proposed Initial Public Offering
NIQ Announces Filing of Registration Statement for Proposed Initial Public Offering

Malaysian Reserve

time5 days ago

  • Business
  • Malaysian Reserve

NIQ Announces Filing of Registration Statement for Proposed Initial Public Offering

CHICAGO, June 27, 2025 /PRNewswire/ — NIQ Global Intelligence plc (the 'Company') announced today that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ('SEC') relating to a proposed initial public offering of its ordinary shares. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the proposed offering may be completed. The number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined. The Company intends to list its ordinary shares on the New York Stock Exchange under the ticker symbol 'NIQ.' J.P. Morgan, BofA Securities, UBS Investment Bank, Barclays and RBC Capital Markets are acting as joint lead book-running managers for the proposed offering. BMO Capital Markets, BNP Paribas, Citigroup, Deutsche Bank Securities, KKR and Wells Fargo Securities are also acting as joint book-running managers. Baird, Capital One Securities, Fifth Third Securities, Needham & Company, SMBC Nikko, Stifel and William Blair are acting as co-managers for the proposed offering. The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to this offering, when available, may be obtained from:J.P. Morgan Securities LLC, Attention: c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or email: prospectus-eq_fi@ and postsalemanualrequests@ BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attention: Prospectus Department, by email: or UBS Securities LLC, 1285 6th Ave, New York, NY 10019, by telephone: (888) 827-7275. A registration statement on Form S-1 relating to the proposed offering has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About NIQNIQ is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world's population and more than $ 7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™. Contact ContactNIQ@ Colleen Hsia, Teneo

McGraw Hill Announces Filing of Registration Statement for Proposed Initial Public Offering
McGraw Hill Announces Filing of Registration Statement for Proposed Initial Public Offering

Business Wire

time5 days ago

  • Business
  • Business Wire

McGraw Hill Announces Filing of Registration Statement for Proposed Initial Public Offering

COLUMBUS, Ohio--(BUSINESS WIRE)--McGraw Hill, Inc. ('McGraw Hill') today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the 'SEC') relating to the proposed initial public offering of shares of its common stock (the 'Common Stock'). The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size, price or other terms of the offering. McGraw Hill intends to list its Common Stock on the New York Stock Exchange under the ticker symbol 'MH.' Goldman Sachs & Co. LLC is acting as book-running manager for the proposed offering and as representative of the underwriters for the proposed offering. BMO Capital Markets, J.P. Morgan, Macquarie Capital, Morgan Stanley, Deutsche Bank Securities, and UBS Investment Bank, are acting as bookrunners for the proposed offering. Baird, BTIG, Needham & Company, Rothschild & Co, Stifel, and William Blair, are acting as co-managers for the proposed offering. The proposed offering will be made only by means of a prospectus. Once available, a copy of the preliminary prospectus relating to the proposed offering may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282 (Tel: 866-471-2526) or by e-mail at prospectus-ny@ A registration statement relating to the Common Stock has been filed with the SEC but has not yet become effective. The Common Stock may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Common Stock, nor shall there be any sale of the Common Stock in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About McGraw Hill McGraw Hill is a leading global provider of education solutions for preK-12, higher education and professional learning, supporting the evolving needs of millions of educators and students around the world. We provide trusted, high-quality content and personalized learning experiences that use data, technology and learning science to help students progress towards their goals. Through our commitment to fostering a culture of innovation and belonging, we are dedicated to improving outcomes and access to education for all. We have over 30 offices across North America, Asia, Australia, Europe, the Middle East and South America, and make our learning solutions available in more than 80 languages.

Carlsmed targets IPO to continue medtech public listing boom
Carlsmed targets IPO to continue medtech public listing boom

Yahoo

time5 days ago

  • Business
  • Yahoo

Carlsmed targets IPO to continue medtech public listing boom

AI-focused spinal surgery firm Carlsmed is planning to go public, adding to a strong year of medtech initial public offerings (IPOs). Carlsmed filed a registration statement on Form S-1 with the US Securities and Exchange Commission (SEC) on 26 July, indicating its intention to go public. The form neither detailed how many shares the device maker is looking to sell nor the price range at which they will be sold, meaning it is not possible to calculate how much the IPO will raise. The Form S-1, used by companies when notifying the SEC of their intent to carry out public offerings, only mentioned that the listing would have occurred on the Nasdaq. Carlsmed has developed a personalised surgery platform called aprevo, which it claims enhances surgical outcomes, lowers the need for revision surgery, and improves long-term outcomes. The company's portfolio comprises implantable lumbar and cervical patient-specific interbody fusion devices and accompanying software. The company already has clearance from the US Food and Drug Administration (FDA) for its lumbar and cervical devices. Whilst its lumbar spine fusion surgery products are commercialised in the US, it expects to market the cervical devices next year. In its S-1 form, Carlsmed said it will pursue additional clearances for its platform throughout 2025. The California-based company estimates an addressable market of approximately $13.4bn for its aprevo platform in the US. Carlsmed's books have had strong growth – the company reported revenue of $27.2m in 2024, up 97.2% from 2023. The IPO will look to add cash resources for the spinal specialist, which already raised $52.5m in Series C financing in March 2024. Carlsmed is the latest medtech company in 2025 to target an IPO. Although it is notable for its AI-driven spinal surgery devices, the company is part of a broader trend of AI-focused medtechs going public. Artificial pancreas maker Beta Bionics raised $204m in a Nasdaq listing in January while wearable defibrillator maker Kestra closed an IPO worth $202m before deductions. The public listings reflect a stronger IPO landscape for medtech companies that have previously suffered in recent times. The first half of 2025 consolidates investor predictions made in December last year, who were optimistic about recovery. "Carlsmed targets IPO to continue medtech public listing boom" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store